BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26370103)

  • 1. Metabolic syndrome in Sjögren's syndrome patients: a relevant concern for clinical monitoring.
    Augusto KL; Bonfa E; Pereira RM; Bueno C; Leon EP; Viana VS; Pasoto SG
    Clin Rheumatol; 2016 Mar; 35(3):639-47. PubMed ID: 26370103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome.
    Rodrigues CE; Vendramini MB; Bueno C; Bonfá E; de Carvalho JF
    Clin Exp Rheumatol; 2012; 30(6):871-8. PubMed ID: 22935544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome.
    Chedraui P; Pérez-López FR; Escobar GS; Palla G; Montt-Guevara M; Cecchi E; Genazzani AR; Simoncini T;
    Maturitas; 2014 Sep; 79(1):86-90. PubMed ID: 25015014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome.
    Kolsgaard ML; Wangensteen T; Brunborg C; Joner G; Holven KB; Halvorsen B; Aukrust P; Tonstad S
    Scand J Clin Lab Invest; 2009; 69(8):858-64. PubMed ID: 19929281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant.
    Anastácio LR; de Oliveira MC; Diniz KG; Ferreira AM; Lima AS; Correia MI; Vilela EG
    Nutrition; 2016 Sep; 32(9):921-7. PubMed ID: 27189907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects.
    de Abreu VG; Martins CJM; de Oliveira PAC; Francischetti EA
    PLoS One; 2017; 12(7):e0180947. PubMed ID: 28746378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose.
    de Luis DA; Sagrado MG; Conde R; Aller R; Izaola O
    Nutrition; 2013; 29(11-12):1300-3. PubMed ID: 19131213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiometabolic risk factors in preschool children with abdominal obesity from Medellín, Colombia.
    Marín-Echeverri C; Aristizábal JC; Gallego-Lopera N; Santa-Ramírez HA; Hoyos-Gómez M; Ruiz-Pineda AM; Arias AA; Barona-Acevedo J
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1179-1189. PubMed ID: 30367807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters.
    Akkus G; Evran M; Sert M; Tetiker T
    Endocr Metab Immune Disord Drug Targets; 2019; 19(3):326-332. PubMed ID: 30306882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the Mediterranean diet on plasma adipokine concentrations in men with metabolic syndrome.
    Richard C; Royer MM; Couture P; Cianflone K; Rezvani R; Desroches S; Lamarche B
    Metabolism; 2013 Dec; 62(12):1803-10. PubMed ID: 23993420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men.
    Gannagé-Yared MH; Khalife S; Semaan M; Fares F; Jambart S; Halaby G
    Eur J Endocrinol; 2006 Jul; 155(1):167-76. PubMed ID: 16793964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waist circumference provides an indication of numerous cardiometabolic risk factors in adults with cerebral palsy.
    Ryan JM; Crowley VE; Hensey O; McGahey A; Gormley J
    Arch Phys Med Rehabil; 2014 Aug; 95(8):1540-6. PubMed ID: 24742941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross-sectional study.
    Ntzouvani A; Fragopoulou E; Panagiotakos D; Pitsavos C; Antonopoulou S
    Lipids Health Dis; 2016 Aug; 15(1):140. PubMed ID: 27567677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the combined use of insulin resistance indices, including adipokines, more reliable in metabolic syndrome?
    Kural B; Değer O; Erem C; Balaban Yücesan F; Aliyazicioğlu R; Barlak Y
    Turk J Med Sci; 2014; 44(6):1021-8. PubMed ID: 25552156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis.
    Rho YH; Chung CP; Solus JF; Raggi P; Oeser A; Gebretsadik T; Shintani A; Stein CM
    Arthritis Rheum; 2010 May; 62(5):1259-64. PubMed ID: 20213808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6.
    Siemińska L; Wojciechowska C; Walczak K; Borowski A; Marek B; Nowak M; Kajdaniuk D; Foltyn W; Kos-Kudła B
    Endokrynol Pol; 2015; 66(5):394-403. PubMed ID: 26457493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.